Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Change in Receivables (2019 - 2025)

AdaptHealth has reported Change in Receivables over the past 7 years, most recently at -$8.8 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$8.8 million for Q4 2025, down 163.57% from a year ago — trailing twelve months through Dec 2025 was -$31.0 million (down 218.19% YoY), and the annual figure for FY2025 was -$31.0 million, down 218.19%.
  • Change in Receivables for Q4 2025 was -$8.8 million at AdaptHealth, up from -$13.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for AHCO hit a ceiling of $40.6 million in Q1 2024 and a floor of -$35.9 million in Q3 2024.
  • Median Change in Receivables over the past 5 years was $4.9 million (2022), compared with a mean of $2.7 million.
  • Peak annual rise in Change in Receivables hit 1728.53% in 2021, while the deepest fall reached 5800.0% in 2021.
  • AdaptHealth's Change in Receivables stood at $4.6 million in 2021, then plummeted by 44.79% to $2.6 million in 2022, then skyrocketed by 633.4% to $18.8 million in 2023, then fell by 26.07% to $13.9 million in 2024, then plummeted by 163.57% to -$8.8 million in 2025.
  • The last three reported values for Change in Receivables were -$8.8 million (Q4 2025), -$13.3 million (Q3 2025), and -$24.3 million (Q2 2025) per Business Quant data.